Alkem Laboratories Limited
ALKEM
Rang in Aktien
#2814
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Aktienkurs
$55.19
Marktkapitalisierung
$6.60B
Veränderung (1 Tag)
-0.06%
Veränderung (1 Jahr)
-12.43%
Land
IN
Handel Alkem Laboratories Limited (ALKEM)
Kategorie
Healthcare
P/S-Verhältnis für Alkem Laboratories Limited (ALKEM)
P/S-Verhältnis zum October 2026 TTM: 4.10
Laut den neuesten Finanzberichten und dem Aktienkurs von Alkem Laboratories Limited beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 4.10. Am Ende des Jahres 2024 lag das P/S-Verhältnis bei 4.77.
P/S-Verlauf für Alkem Laboratories Limited von 2010 bis 2026
P/S-Verhältnis zum Jahresende
| Jahr | P/S-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 4.10 | -7.97% |
| 2025 | 4.46 | -6.42% |
| 2024 | 4.77 | 36.13% |
| 2023 | 3.50 | -14.01% |
| 2022 | 4.07 | 8.45% |
| 2021 | 3.75 | 10.57% |
| 2020 | 3.39 | 18.05% |
| 2019 | 2.88 | -20.88% |
| 2018 | 3.63 | -22.57% |
| 2017 | 4.69 | 40.82% |
| 2016 | 3.33 | -25.09% |
| 2015 | 4.45 | -17.15% |
| 2014 | 5.37 | -24.64% |
| 2013 | 7.13 | -15.73% |
| 2012 | 8.46 | -15.41% |
| 2011 | 10.00 | -18.68% |
| 2010 | 12.29 | 0.00% |
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/S-Verhältnis | P/S-Verhältnis-Differenz | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | 71.94% |
IN
|
